Drug
Avn 944 For Administration
Avn 944 For Administration: highest development phase Phase 1, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| AVN-944 capsules for oral administration NCT00273936 | Phase 1 | Acute Leukemia |
Latest
No recent events.
Follow Avn 944 For Administration on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.